Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 121

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment

Kim, Chaeyoung, Nam, Dong Woo, Park, Sang Yoon, Song, Hyundong, Hong, Hyun Seok, Boo, Jung Hyun, Jung, Eun Sun, Kim, Yoonhee, Baek, Ju Yuel, Kim, Kwan Soo, Cho, Jin Won, Mook-Jung, Inhee·2013·Neurobiology of Aging

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2012.03.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 31

  1. Butkinaree, 2010, O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress, Biochim. Biophys. Acta, 1800, 96, 10.1016/j.bbagen.2009.07.018 · DOI · Paper page
  2. Chalkley, 2003, Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry, Mol. Cell. Proteomics, 2, 182, 10.1074/mcp.M300027-MCP200 · DOI
  3. De Strooper, 2005, Nicastrin: gatekeeper of the gamma-secretase complex, Cell, 122, 318, 10.1016/j.cell.2005.07.021 · DOI
  4. Farmery, 2003, Partial purification and characterization of gamma-secretase from post-mortem human brain, J. Biol. Chem, 278, 24277, 10.1074/jbc.M211992200 · DOI
  5. Griffith, 1995, Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine, J. Neurosci. Res, 41, 270, 10.1002/jnr.490410214 · DOI
  6. Hong, 2010, FK506 reduces amyloid plaque burden and induces MMP-9 in AbetaPP/PS1 double transgenic mice, J. Alzheimers Dis, 22, 97, 10.3233/JAD-2010-100261 · DOI
  7. Iwatsubo, 2004, The gamma-secretase complex: machinery for intramembrane proteolysis, Curr. Opin. Neurobiol, 14, 379, 10.1016/j.conb.2004.05.010 · DOI · Paper page
  8. Jacobsen, 2011, O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP), Biochem. Biophys. Res. Commun, 404, 882, 10.1016/j.bbrc.2010.12.080 · DOI
  9. Jankowsky, 2001, Co-expression of multiple transgenes in mouse CNS: a comparison of strategies, Biomol. Eng, 17, 157, 10.1016/S1389-0344(01)00067-3 · DOI · Paper page
  10. Jin, 2007, DNA damage-inducing agent-elicited gamma-secretase activity is dependent on Bax/Bcl-2 pathway but not on caspase cascades, Cell Death Differ, 14, 189, 10.1038/sj.cdd.4402003 · DOI
  11. Karlström, 2002, A sensitive and quantitative assay for measuring cleavage of presenilin substrates, J. Biol. Chem, 277, 6763, 10.1074/jbc.C100649200 · DOI
  12. Kim, 2003, Regulated hyperaccumulation of presenilin-1 and the “gamma-secretase” complex, J. Biol. Chem, 278, 33992, 10.1074/jbc.M305834200 · DOI
  13. Kimura, 2009, Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, Neurobiol. Dis, 33, 229, 10.1016/j.nbd.2008.10.006 · DOI · Paper page
  14. Kochi, 1999, Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells, Eur. J. Pharmacol, 372, 287, 10.1016/S0014-2999(99)00247-2 · doi:10.1016/s0014-2999(99)00247-2
  15. Kreppel, 1997, Dynamic glycosylation of nuclear and cytosolic proteins, J. Biol. Chem, 272, 9308, 10.1074/jbc.272.14.9308 · DOI · Paper page
  16. Lalonde, 2002, The neurobiological basis of spontaneous alternation, Neurosci. Biobehav. Rev, 26, 91, 10.1016/S0149-7634(01)00041-0 · DOI · Paper page
  17. Lester-Coll, 2006, Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease, J. Alzheimers Dis, 9, 13, 10.3233/JAD-2006-9102 · DOI · Paper page
  18. Liu, 2008, Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease, FEBS Lett, 582, 359, 10.1016/j.febslet.2007.12.035 · DOI · Paper page
  19. Macauley, 2010, Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes, Chem. Biol, 17, 937, 10.1016/j.chembiol.2010.07.006 · DOI
  20. Macauley, 2010, Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis, Chem. Biol, 17, 949, 10.1016/j.chembiol.2010.07.005 · DOI
  21. Macauley, 2005, O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors, J. Biol. Chem, 280, 25313, 10.1074/jbc.M413819200 · DOI · Paper page
  22. McGeer, 1989, Cortical glutaminase, beta-glucuronidase and glucose utilization in Alzheimer's disease, Can. J. Neurol. Sci, 16, 511, 10.1017/S0317167100029851 · DOI
  23. Moon, 2011, Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice, J. Alzheimers Dis, 23, 147, 10.3233/JAD-2010-101263 · DOI
  24. Morais, 2003, The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the gamma-secretase complex, J. Biol. Chem, 278, 43284, 10.1074/jbc.M305685200 · DOI
  25. Robertson, 2003, Characterization of plasma inhibin forms in fertile and infertile men, Hum. Reprod, 18, 1047, 10.1093/humrep/deg225 · doi:10.1093/humrep/deg225
  26. Shah, 2005, Nicastrin functions as a gamma-secretase-substrate receptor, Cell, 122, 435, 10.1016/j.cell.2005.05.022 · DOI · Paper page
  27. Tallent, 2009, In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation, J. Biol. Chem, 284, 174, 10.1074/jbc.M807431200 · DOI
  28. Vosseller, 2002, Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes, Proc. Natl. Acad. Sci. U. S. A., 99, 5313, 10.1073/pnas.072072399 · DOI · Paper page
  29. Wells, 2001, Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc, Science, 291, 2376, 10.1126/science.1058714 · DOI · Paper page
  30. Yang, 2006, Thermal and UV shape shifting of surface topography, J. Am. Chem. Soc, 128, 1074, 10.1021/ja056866s · DOI
  31. Yuzwa, 2008, A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo, Nat. Chem. Biol, 4, 483, 10.1038/nchembio.96 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., Cho, J. W., & Mook-Jung, I.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2013-01
Volume
34
Issue
1
Pages
275-285
ISSN
0197-4580
Cited by
121
References
3
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Research Foundation of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2012.03.001
The paper
Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., Cho, J. W., & Mook-Jung, I. (2013). O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2012.03.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.